title: Haemostasis. Part 2: Medications that affect haemostasis.
abstract: Post-operative haemorrhage is a recognized complication in dental practice. This may be more prevalent in patients taking antithrombotic medications. It is important that the dentist understands the mechanism of action of these drugs and how they may affect management of dental patients. Clinical Relevance: Dental professionals must be aware of those medications affecting haemostasis and how they may impact on management. The emergence of different therapeutic regimens has increased the number of such drugs.
authors: Neal J
authors: NJ
authors: McCormick
authors: Undrell J
authors: UJ
authors: Moore
authors: John G
authors: JG
authors: Meechan
authors: Mohsen
authors: M
authors: Norouzi
mesh_terms: D000925:Anticoagulants / Q000627:therapeutic use; D000991:Antithrombins / Q000627:therapeutic use; D001562:Benzimidazoles / Q000627:therapeutic use; D000069604:Dabigatran; D004347:Drug Interactions; D005343:Fibrinolytic Agents / Q000627:therapeutic use; D006401:Hematologic Agents / Q000145:classification / Q000627:therapeutic use*; D006488:Hemostasis, Surgical / Q000379:methods*; D006493:Heparin / Q000627:therapeutic use; D006801:Humans; D019934:International Normalized Ratio; D006472:Oral Hemorrhage / Q000517:prevention & control*; D010975:Platelet Aggregation Inhibitors / Q000627:therapeutic use; D019106:Postoperative Hemorrhage / Q000517:prevention & control*; D018570:Risk Assessment; D014859:Warfarin / Q000627:therapeutic use; D015091:beta-Alanine / Q000031:analogs & derivatives / Q000627:therapeutic use
chemical_list: D000925:Anticoagulants; D000991:Antithrombins; D001562:Benzimidazoles; D005343:Fibrinolytic Agents; D006401:Hematologic Agents; D010975:Platelet Aggregation Inhibitors; D015091:beta-Alanine; D014859:Warfarin; D006493:Heparin; D000069604:Dabigatran